Study | Selection | Comparability | Outcome | Overall | |||||
---|---|---|---|---|---|---|---|---|---|
Representativeness of exposed cohort | Selection of nonexposed | Ascertainment of exposure | Outcome not present at start | Study controls for treatment | Assessment of outcome | Adequate follow-up length | Adequacy of follow-up | ||
Lane (2018) | *a | * | * | * | *d | * | * | * | 8 |
Anan (2017) | *b | * | * | * | - | * | * | * | 7 |
Hinata (2017) | *b | * | * | * | *e | * | * | * | 8 |
Martinez-Pineiro (1995) | *b | * | * | * | *f | * | * | * | 8 |
Milenkovic (2018) | -c | * | * | * | -g | * | * | * | 6 |
Mozzane (2019) | *a | * | * | * | *d,e | * | * | * | 8 |
Gronostaj (2019) | -c | * | * | * | -g | * | * | * | 6 |
Boeri (2019) | -a | * | * | * | *e | * | * | * | 7 |
Nitta (2019) | *b | * | * | * | -g | * | *i | * | 7 |
Ploussard (2020) | *b | * | * | * | – | * | * | * | 7 |
Russell (2019) | *a | * | * | * | *e | * | * | * | 8 |
Vetterlein (2017) | *a | * | * | * | *d | * | * | * | 8 |
Hermans (2019) | *a | * | * | * | -h | * | * | * | 7 |